Response To: ‘Clinical Benefit of Vedolizumab on Articular Manifestations in Patients With Active Spondyloarthritis Associated With Inflammatory Bowel Disease’ by Orlando Et Al

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2016-211045
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ


Related search